Dr. Liliya Vasileva

 

 

 

 

 

 

 

Position: Postdoctoral researcher

Department: Plant Cell Biotechnology, CPSBB

Her early work focused on pharmacological modulation of chronic stress, immunoreactivity and inflammation through plant-derived extracts and bioactive compounds in in vivo model systems. Dr. Vasileva has developed extensive expertise in experimental pharmacology and ethnopharmacology.
The main area of Liliya`s research is modulation of obesity mechanisms through plant extracts and bioactive phytochemicals using in vitro model of human SGBS adipocytes.
Liliya is also interested in studying the effects of pharmacological modulation with natural compounds of the transcription factor Nrf2 in different in vitro models, the cytotoxic potential of plant extracts in breast cancer and chronic skin inflammations.

SELECTED PUBLICATIONS:

Georgiev M.I., Vasileva L.V., Savova M.S. (2021) Antiobesity molecules of natural origin: Call for lead finding acceleration. Food Frontiers. DOI: 10.1002/fft2.59.

Vasileva L.V., Savova M.S., Tews D., Wabitsch M., Georgiev M.I. (2021) Rosmarinic acid attenuates obesity and obesity-related inflammation in human adipocytes. Food and Chemical Toxicology. 149: 112202. (IF 4.679)

Vasileva L., Savova M., Amirova K., Balcheva-Sivenova Zh., Ferrante C., Orlando G., Wabitsch M. , Georgiev M.I. (2020) Caffeic and chlorogenic acids synergistically activate browning program in human adipocytes: Implications of AMPK and PPAR-mediated Pathways. International Journal of Molecular Sciences. 21: 9740. (IF 4.556)

Vasileva L., Savova M., Amirova K., Dinkova-Kostova A., Georgiev M.I. (2020) Obesity and NRF2-mediated cytoprotection: Where is the missing link? Pharmacological Research. 156: 104760. (IF 5.893)

Vasileva L, Marchev A, Georgiev M (2018) Causes and solutions to “globesity”: The new fa(s)t alarming global epidemic. Food and Chemical Toxicology 121: 173-193. (IF 3.775)